MA43682A - Procédés de traitement de l'intolérance au lactose - Google Patents

Procédés de traitement de l'intolérance au lactose

Info

Publication number
MA43682A
MA43682A MA043682A MA43682A MA43682A MA 43682 A MA43682 A MA 43682A MA 043682 A MA043682 A MA 043682A MA 43682 A MA43682 A MA 43682A MA 43682 A MA43682 A MA 43682A
Authority
MA
Morocco
Prior art keywords
treatment methods
lactose intolerance
intolerance treatment
lactose
methods
Prior art date
Application number
MA043682A
Other languages
English (en)
French (fr)
Inventor
Salvatore Bellinvia
Marie Mcnulty
Francesca Viti
Original Assignee
Nogra Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nogra Pharma Ltd filed Critical Nogra Pharma Ltd
Publication of MA43682A publication Critical patent/MA43682A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
MA043682A 2016-02-26 2017-02-27 Procédés de traitement de l'intolérance au lactose MA43682A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662300376P 2016-02-26 2016-02-26

Publications (1)

Publication Number Publication Date
MA43682A true MA43682A (fr) 2018-11-28

Family

ID=58162625

Family Applications (1)

Application Number Title Priority Date Filing Date
MA043682A MA43682A (fr) 2016-02-26 2017-02-27 Procédés de traitement de l'intolérance au lactose

Country Status (6)

Country Link
US (1) US20190046490A1 (https=)
EP (1) EP3419616A1 (https=)
JP (1) JP7125350B2 (https=)
CA (1) CA3014575A1 (https=)
MA (1) MA43682A (https=)
WO (1) WO2017144725A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2805746T1 (sl) 2009-02-16 2020-10-30 Nogra Pharma Limited Alkilamido spojine in njihova uporaba
CA2864059C (en) 2012-02-09 2020-04-28 Nogra Pharma Limited Methods of treating fibrosis
EP4495101A3 (en) 2019-02-08 2025-04-30 Nogra Pharma Limited Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
CA2313626A1 (en) 1997-12-12 1999-06-17 Purdue Research Foundation Methods and compositions for treating diabetes
US7015249B1 (en) * 1997-12-12 2006-03-21 Purdue Research Foundation Methods and compositions for treating diabetes
AU2002357729A1 (en) * 2001-11-16 2003-06-10 Nutrition 21, Inc. Trans-10, cis-12 conjugated linoleic acid isomer for the treatment of diseases
EP1719543A1 (en) * 2005-05-04 2006-11-08 Asan Labs., Ltd. Use of histone deacetylase inhibitors for the treatment of gastrointestinal distress
WO2007096148A1 (en) * 2006-02-23 2007-08-30 Lipid Nutrition B.V. Immunoregulation
IE20070129A1 (en) 2007-02-28 2008-12-24 Giuliani Int Ltd Ppar-gamma agonists stimulate enteric defensin expression
US20090264520A1 (en) * 2008-04-21 2009-10-22 Asha Lipid Sciences, Inc. Lipid-containing compositions and methods of use thereof
ES2627745T3 (es) 2008-11-13 2017-07-31 Nogra Pharma Limited Composiciones antisentido, y procedimientos de fabricación y uso de las mismas
MX2014012652A (es) 2012-04-18 2014-11-25 Nogra Pharma Ltd Metodo de tratamiento de la intolerancia a la lactosa.
JP6096179B2 (ja) * 2012-05-10 2017-03-15 国立大学法人岩手大学 ラクターゼ活性を有するタンパク質、該タンパク質をコードする遺伝子、該遺伝子を含有する組み換えベクター、形質転換体、及びその製造方法並びに用途
PE20160037A1 (es) * 2013-03-26 2016-02-04 Lipid Therapeutics Gmbh Formulacion farmaceutica que comprende fosfatidilcolina para el tratamiento de colitus ulcerosa

Also Published As

Publication number Publication date
US20190046490A1 (en) 2019-02-14
JP7125350B2 (ja) 2022-08-24
EP3419616A1 (en) 2019-01-02
CA3014575A1 (en) 2017-08-31
WO2017144725A1 (en) 2017-08-31
JP2019510745A (ja) 2019-04-18

Similar Documents

Publication Publication Date Title
MA45192A (fr) Traitement d'association
MA47208A (fr) Procédés de traitement du cancer à l'aide d'anticorps anti-pd-1
EP3496739A4 (en) COMPOSITIONS AND METHODS FOR TREATING PULMONAL HYPERTENSION
MA55748A (fr) Procédés de détection d'aav
EP3426250A4 (en) TREATMENT PROCEDURE
EP3433815A4 (en) ADAPTABLE AUTHENTICATION PROCESSING
EP3601536A4 (en) TREATMENT PROCEDURES
IL269490B (en) Surface treatment methods and compositions therefor
EP3443094A4 (en) PROCESS FOR REDUCING C9ORF72 EXPRESSION
HUE053239T2 (hu) Humanizált tau-ellenanyagok Alzheimer-kór kezelésére
EP3500289A4 (en) METHOD FOR TREATING TRACHEOBRONCHOMALACY
FR3036037B1 (fr) Harnais d'encordement perfectionne
EP3390642A4 (en) COMPOSITIONS AND METHODS OF TREATING RETINITIS PIGMENTOSA 18 AND RETINITIS PIGMENTOSA 13
EP3341391A4 (en) COMPOSITIONS AND METHODS OF PAIN TREATMENT
EP3389657A4 (en) METHOD FOR THE TREATMENT OF HYPERALGESIA
EP3331542A4 (en) COMPOSITIONS AND METHODS OF TREATING CANCER ASSOCIATED WITH ETBR ACTIVATION
EP3433383A4 (en) PROCESS FOR QUANTITATIVE AMPLIFICATION
EP3625971A4 (en) SPATIAL AUDIO PROCESSING
EP3409744A4 (en) SURFACE TREATMENT AGENT
MA46062A (fr) Traitement par ascaroside de l'oesophagite à éosinophiles
EP3558312A4 (en) METHODS FOR INCREASING VASCULAR DENSITY
IL263433A (en) Methods for treating alzheimer's disease
IL262588A (en) Humanized anti-basigin antibodies and the use thereof
EP3402575A4 (en) METHOD AND COMPOSITIONS FOR TREATING DAMAGED HAIR
IL256000A (en) Quantifying her 2 protein for optimal cancer therapy